KP

Kunnoth Parambath Jiran Prasad

Active Director Director DIN 08600079
DIN 08600079 First appointment Oct 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Kunnoth Parambath Jiran Prasad

Data last updated:

Kunnoth Parambath Jiran Prasad is a Director at Liaise Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Liaise Pharmaceuticals Private Limited reported revenue of ₹50.1 Lakh (FY 2024).

DIN 08600079
Primary Designation Director
Industry Chemicals
First Appointment 31 Oct 2019
Oldest Company Age 7 yrs
Largest company Liaise Pharmaceuticals Private Limited · ₹50.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Oct 20192019₹50.1 Lakh (FY 2024)Active

Board colleagues of Kunnoth Parambath Jiran Prasad

Directorship timeline

Open interactive timeline →
Liaise Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kunnoth Parambath Jiran Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunnoth Parambath Jiran Prasad

Kunnoth Parambath Jiran Prasad currently holds 1 directorship: Liaise Pharmaceuticals Private Limited (Director, since 31 Oct 2019, revenue ₹50.1 Lakh (FY 2024)).

Kunnoth Parambath Jiran Prasad was first appointed on 31 Oct 2019 as Director at Liaise Pharmaceuticals Private Limited.

The current boards of Kunnoth Parambath Jiran Prasad's companies include Sajinkumar Peedika Parambath (Liaise Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available